Sinsin Pharmaceutical Co. Ltd - Asset Resilience Ratio

Latest as of March 2025: 0.73%

Sinsin Pharmaceutical Co. Ltd (002800) has an Asset Resilience Ratio of 0.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩958.68 Million

≈ $649.69K USD Cash + Short-term Investments

Total Assets

₩131.93 Billion

≈ $89.41 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Sinsin Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Check 002800 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Sinsin Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sinsin Pharmaceutical Co. Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩958.68 Million	0.73%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩958.68 Million	0.73%

Asset Resilience Insights

Limited Liquidity: Sinsin Pharmaceutical Co. Ltd maintains only 0.73% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Sinsin Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Sinsin Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Sinsin Pharmaceutical Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Sinsin Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.42%	₩539.85 Million ≈ $365.85K	₩129.48 Billion ≈ $87.75 Million	+0.14pp
2023-12-31	0.28%	₩346.46 Million ≈ $234.79K	₩124.41 Billion ≈ $84.31 Million	-1.57pp
2022-12-31	1.85%	₩2.24 Billion ≈ $1.52 Million	₩121.21 Billion ≈ $82.14 Million	+1.15pp
2021-12-31	0.70%	₩799.33 Million ≈ $541.70K	₩114.31 Billion ≈ $77.46 Million	-1.42pp
2020-12-31	2.12%	₩2.50 Billion ≈ $1.70 Million	₩118.13 Billion ≈ $80.06 Million	+1.03pp
2019-12-31	1.09%	₩1.41 Billion ≈ $955.48K	₩129.24 Billion ≈ $87.58 Million	-0.92pp
2018-12-31	2.01%	₩2.17 Billion ≈ $1.47 Million	₩107.92 Billion ≈ $73.14 Million	-7.58pp
2017-12-31	9.59%	₩7.56 Billion ≈ $5.12 Million	₩78.85 Billion ≈ $53.44 Million	+9.18pp
2016-12-31	0.41%	₩280.00 Million ≈ $189.75K	₩68.81 Billion ≈ $46.63 Million	--

pp = percentage points

About Sinsin Pharmaceutical Co. Ltd

KQ:002800 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.39 Million

₩64.02 Billion KRW

Market Cap Rank

#22387 Global

#1391 in Korea

Share Price

₩4220.00

Change (1 day)

+1.93%

52-Week Range

₩4015.00 - ₩6630.00

All Time High

₩13396.03